Skip to main content
Log in

Cryopreserved arterial homografts: Preliminary study

  • Original Articles
  • Published:
Annals of Vascular Surgery

Abstract

The use of arterial or venous allografts for vascular reconstruction was first reported in 1951, but long-term results have been disappointing. Rejection and inappropriate methods of preservation are the main reasons for failure. A successful solution to this problem could be achieved by programmed cryopreservation with cryoprotectant. Our study had two aims: to define the biomechanical properties of cryopreserved arterial allografts and to study their histologic appearance. Arteries were removed as part of a protocol for multiorgan harveting for transplantation. Cryopreservation was performed within the first 24 hours after harvesting. Programmed cryopreservation with 15% dimethyl sulfoxide (cryoprotectant) was used. Mechanical testing was done immediately after thawing. Two groups were tested: a control group of fresh aortas and a group of cryopreserved aortas. Axial and circumferential strips were tested. High strain modulus and stress and strain characteristics were calculated for each strip. There was no statistically significant difference between the mechanical properties of fresh and cryopreserved human descending thoracic aortas. Biochemical tests were performed in the preservative solution at 1 and 7 days in both groups. There was no statistically significant difference between the two groups at day 1 or day 7 (p > 0.05). Histologic studies before and after arterial cryopreservation included standard and electron microscopy and showed that arteries had normal structure after cryopreservation. These results confirm that programmed cryopreservation with cryoprotectant does not alter the molecular or geometric configuration of collagen or elastic fibers. Endothelial cells were still present; however, their viability and function were not assessed. The results of our studies have encouraged us to use cryopreserved arterial allografts for clinical application, and to date 27 patients have received cryopreserved arterial allografts. Definitive results including histologic and immunologic findings will be reported in the future when the length of follow-up is adequate.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Oudot J. La greffe vasculaire dans les thromboses du carre-four aortique. Presse Med 1951;59:234–236.

    PubMed  Google Scholar 

  2. Gross RE, Bill AH, Pierce EC. Methods for preservation and transplantation of arterial grafts. Observations on arterial grafts in dogs. Report of transplantation of preserved arterial grafts in 9 human cases. Surg Gynecol Obstet 1949;88:689–695.

    Google Scholar 

  3. Dubost C, Allary M, Oeconomos N. Anévrysme de l'aorte abdominale traité par résection et greffe. Arch Mal Coeur 1951;44:848–851.

    PubMed  Google Scholar 

  4. Veterans Administration Study Group 141. Comparative evaluation of prosthetic, reversed, and in situ vein bypass grafts in distal popliteal and tibial-peroneal vascularization. Arch Surg 1988;123:434–438.

    Google Scholar 

  5. Dennis JW, Littooy FN, Greisler HP, et al. Secondary vascular procedure with polytetrafluoroethylene grafts for lower extremity ischemia in male veteran population. J Vasc Surg 1988;8:137–142.

    PubMed  Google Scholar 

  6. DeBakey ME. Les greffes d'aortes. In Fontaine R, Dubost C, eds. Les Greffes Vasculaires: Rapport du 56ème Congrès Français de Chirurgie. Paris: Presse Universitaire de France, 1954, pp 264–265.

    Google Scholar 

  7. Rob C. Obliterations of the aortic bifurcation (Leriche's syndrome): Surgical treatment. Minerva Cardioangiol Eur 1957;5:110–116.

    Google Scholar 

  8. Cockett FB. Obliteration du carrefour aortique (syndrome de Leriche). Minerva Cardioangiol Eur 1957;5:143.

    Google Scholar 

  9. Szilagyi DE, Rodriguez FT, Smith RF, et al. Late fate of arterial homografts: Observations 6 to 15 years after implantation. Arch Surg 1970;101:721–733.

    PubMed  Google Scholar 

  10. Ross DN. Homograft replacement of the aortic valve. Lancet 1962;2:487–494.

    PubMed  Google Scholar 

  11. Barratt-Boyes BG. Homograft aortic valve replacement in aortic incompetence and stenosis. Thorax 1964;19:131–141.

    PubMed  Google Scholar 

  12. Paneth M, O'Brien MF. Transplantation of human homograft aortic value. Thorax 1966;21:115–123.

    PubMed  Google Scholar 

  13. Barratt-Boyes BG. Long-term follow-up of aortic valve grafts. Br Heart J 1971;33:60–71.

    PubMed  Google Scholar 

  14. Carpentier A, Lemaigre G, Ladislas R, et al. Biological factors affecting long-term results of valvular heterografts. J Thorac Cardiovasc Surg 1969;58:467–483.

    PubMed  Google Scholar 

  15. Mailligan DJ, Lewis JW, Tilley B, et al. The porcine bioprosthetic valve. Twelve years later. J Thorac Cardiovasc Surg 1963;46:726–743.

    PubMed  Google Scholar 

  16. Walter P, Schmitz H. La Prothèse Vasculaire Hétérologue. Aulendorf: Edition Cantor, 1976.

    Google Scholar 

  17. Stanisic M, Gloor F. Observations histologiques sur les prothèses vasculaires bovines implantées chez l'homme. In Walter P, Schmitz H, ed. La Prothèse Vasculaire Hétérologue. Aulendorf: Edition Cantor, 1976, pp 57–62.

    Google Scholar 

  18. Angell WW, De Lanerolle P, Shumway NE, et al. Valve replacement: Present status of homograft valves. Prog Cardiovasc Dis 1973;15:589–596.

    PubMed  Google Scholar 

  19. Watts LK, Duffy P, Field B, et al. Establishment of a viable homograft cardiac bank: A rapid method of determining homograft viability. Ann Thorac Surg 1976;21:230–238.

    PubMed  Google Scholar 

  20. O'Brien MF. Comparison of fresh antibiotic sterilized and cryopreserved viable homografts: Fifteen-year and ten-year clinical experience [abst]. Presented at the International Symposium on the Aortic Root. San Diego: October 1985.

  21. Ochsner JL, Decamp PT, Leonard GL. Experience with fresh venous allografts as an arterial substitute. Ann Surg 1971;173:933–939.

    PubMed  Google Scholar 

  22. Tice DA, Zerbino VR. Clinical experience with preserved human allografts for vascular reconstruction. Surgery 1972;72:260–267.

    PubMed  Google Scholar 

  23. Stephen M, Sheil P, Wong J. Allograft vein arterial bypass. Arch Surg 1978;113:591–593.

    PubMed  Google Scholar 

  24. Bical O, Bachet J, Laurian C, et al. Aortocoronary bypass with homologous saphenous vein: Long-term results. Ann Thorac Surg 1980;30:550–557.

    PubMed  Google Scholar 

  25. Gelbfish J, Jacobowitz IJ, Rose DM, et al. Cryopreserved homologous saphenous vein: Early and late patency in coronary artery bypass surgical procedures. Ann Thorac Surg 1986;42:70–73.

    PubMed  Google Scholar 

  26. Weber TR, Dent TL, Lindenauer SM, et al. Viable vein graft preservation. J Surg Res 1975;18:247–255.

    PubMed  Google Scholar 

  27. Boren HC, Roon AJ, Moore WS. Maintenance of viable arterial allografts by cryopreservation. Surgery 1978;83:382–391.

    PubMed  Google Scholar 

  28. O'Brien MF, Stafford G, Gardner M, et al. The viable cryopreserved allograft aortic valve. J Cardiac Surg 1987;2(Suppl):153–167.

    Google Scholar 

  29. Sellke FW, Meng RL, Rossi NP. Cryopreserved saphenous vein homografts for femoro-distal vascular reconstruction. J Cardiovasc Surg 1989;30:838–842.

    Google Scholar 

  30. Vassoille R, Perez J. Bases physiques et thermodynamiques de la cryobiologie. Innov Tech Biol Med 1984;5:177–230.

    Google Scholar 

  31. Lebaud PH, Oddou L, Ersham A, et al. Replacement des vaisseaux: Greffons artériels cryoconservés pour accès au sang. Innov Tech Biol Med 1984;5:109–116.

    Google Scholar 

  32. Brockbank KG, Bank HL. Measurement of postcryopreservation viability. J Cardiac Surg 1987;2(Suppl):145–141.

    Google Scholar 

  33. Axthelm SC, Porter JM, Strickland S, et al. Antigenicity of venous allografts. Ann Surg 1979;189:290–293.

    PubMed  Google Scholar 

  34. Giordano JM, Lamoy RE, Wright CB, et al. A comparison of autografts and frozen, irradiated homografts in canine femoral venous reconstruction. Surgery 1977;81:100–104.

    Google Scholar 

  35. Schmitz-Rizen T, Megerman J, Colvin RB, et al. Immunosuppressive treatment of aortic allografts. J Vasc Surg 1988;7:82–91.

    PubMed  Google Scholar 

  36. Balch CM, Karp RB. Blood group compatibility and aortic valve allotransplantation in man. J Thorac Cardiovasc Surg 1975;70:256–259.

    PubMed  Google Scholar 

  37. Tice DA, Zerbino VR, Isom OW, et al. Coronary artery bypass with freeze-preserved saphenous vein allografts. J Thorac Cardiovasc Surg 1976;71:378–382.

    PubMed  Google Scholar 

  38. Calhoun AD, Baur G, Portier JM, et al. Fresh and cryopreserved venous allografts in genetically characterized dogs. J Surg Res 1977;22:687–696.

    PubMed  Google Scholar 

  39. Perloff LJ, Reckard CR, Rowlands DT Jr, et al. The venous homograft: An immunological question. Surgery 1972;72:961–970.

    PubMed  Google Scholar 

  40. Williams GM, Haar A, Krajewskic, C, et al. Rejection and repair of endothelium in major vessel transplants. Surgery 1975;78:694–706.

    PubMed  Google Scholar 

  41. Ricotta JJ, Collins GJ, Rich NM, et al. Failure of immuno-suppression to prolong venous allograft survival. Arch Surg 1980;115:99–101.

    PubMed  Google Scholar 

  42. L'Italien GJ, Maloney RD, Abbott WM. The preservation of the mechanical properties of venous allografts by freezing. J Surg Res 1979;27:239–243.

    PubMed  Google Scholar 

  43. Vesely I, Gonzalez-Lavin L, Graf D, et al. Mechanical testing of cryopreserved aortic allografts. Comparison with xenografts and fresh tissue. J Thorac Cardiovasc Surg 1990;99:119–123.

    PubMed  Google Scholar 

  44. Malone JM, Moore WS, Kischer CW, et al. Venous cryopreservation: Endothelial fibrinolytic activity and histology. J Surg Res 1980;29:209–222.

    PubMed  Google Scholar 

  45. Sachs SM, Ricotta JJ, Scott DE, et al. Endothelial integrity after venous cryopreservation. J Surg Res 1982;32:218–227.

    PubMed  Google Scholar 

  46. Bank HL, Schmehl MK, Warner R, et al. Transplantation of cryopreserved canine venous allografts. J Surg Res 1991;50:57–64.

    PubMed  Google Scholar 

  47. Morinaga K, Eguchi H, Miyazaki T, et al. Development and regression of intimal thickening of arterially transplanted autologous vein grafts in dogs. J Vasc Surg 1987;5:719–730.

    PubMed  Google Scholar 

  48. Ricotta JJ, Schaff HV, Gadaz TR. The effect of aspirin and dipyridamole on the patency of allograft vein. J Surg Res 1979;26:262–269.

    Google Scholar 

  49. Chess L, McDermott RP, Schlossman SF. Immunologic function of isolated leukocyte subpopulations. Quantitative isolation of human T and B cells and response to mitogens. J Immunol 1974;813:1113–1125.

    Google Scholar 

  50. Daar AS, Fuggle SV, Fabre JW, et al. The detailed distribution of HLA-A,B,C antigens in normal human organs. Transplantation 1984;38:287–300.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Gournier, JP., Adham, M., Favre, JP. et al. Cryopreserved arterial homografts: Preliminary study. Annals of Vascular Surgery 7, 503–511 (1993). https://doi.org/10.1007/BF02000144

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02000144

Keywords

Navigation